Exploration of a holistic management procedure for liver cancer surveillance to improve the early diagnosis of liver cancer in Chinese population
Yong Li(Sutherland Hospital), Jie Dong(University of Science and Technology of China), Xiaolei Zhou(Guangxi Medicinal Botanical Garden), Manhua Zhong, Xiaofeng Wang(Cleveland Clinic Lerner College of Medicine), Chao Yang(Hunan University), Yanhong Chen(Xuzhou Central Hospital), Qing Yang(Guangzhou University of Chinese Medicine), Linfang Li, Ligong Lu(Tongji University)
Cited by 0
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533